NCT01413893View on ClinicalTrials.gov

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

linifanib

QD daily

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY